What the data says
Carta published its State of Private Markets report for Q3 2026 in early November. Companies on its platform raised $49.3 billion across 1,179 rounds in the quarter, and total deal count was down 21% from a year earlier. Money is still flowing. It is going to fewer companies.
A quick piece of arithmetic on those two numbers: $49.3 billion across 1,179 rounds works out to roughly $42 million per round. That is an average pulled upward by very large late-stage and AI deals, so it says little about the round a typical founder is trying to close. The stage-by-stage figures say more.
The figures below come from The Fund CFO newsletter's November 10 summary of the Carta report. The full Carta report was not accessible to us when this was written, so treat these as secondhand and check them against Carta's report before putting them in a deck or an investor update.
Seed and Series A: higher prices, fewer cheques
According to that summary, seed investors deployed $4.1 billion in Q3, up 21% year over year, but into only 426 rounds, down 27%. Dividing one by the other gives about $9.6 million per seed round on average, again our own arithmetic and not a Carta statistic. The pattern is clear enough: more capital, concentrated in fewer companies.
Series A looks similar. Carta counted 365 Series A rounds in Q3, down 22%. The median pre-money valuation at seed is $19.7 million in 2026, up 84% from 2021, and at Series A it is $63.3 million, up 56% from 2021, per the same summary. These are pre-money figures. Other outlets quote Carta post-money numbers from different periods, so make sure you compare like with like. If a banker, lawyer or angel cites a different median, ask whether it is pre- or post-money and which quarter it covers.
What this means for a founder: a median valuation is not a floor. When round counts fall while the median rises, part of the rise may reflect weaker companies not closing at all, which would leave the stronger ones in the sample. Benchmarking your ask against the median assumes you are a median company that got funded, which is a higher bar than it sounds.
Bridges are still a third of Series A
The summary reports that about one in three Series A rounds in 2026 was a bridge, up from 29% last year. A bridge is a smaller, interim raise, often from existing investors, that buys time to hit the milestones a full round would require.
Two things follow. First, a bridge is no longer a signal of distress by itself. When roughly a third of Series A rounds take that form, investors see them constantly. Second, the terms still matter more than the label. A bridge on a convertible note with a cap and discount is a different instrument from a small priced extension, and the choice affects dilution, the next round's price, and how much leverage your existing investors hold.
If you are planning one, agree in advance with your lead what milestone the bridge funds and what the next round needs to look like. A bridge with no stated finish line tends to become a second bridge.
Down rounds fall, but participating preferred creeps up
Down rounds made up 12.8% of priced rounds in Q3, the lowest rate in four years, versus a peak of 23.4% in early 2024, per the summary. That is the headline reason founders feel better about pricing.
The less comfortable number sits in the terms. More than 10% of Q3 rounds included participating preferred stock, the highest share in six years, according to the same source. Participating preferred lets an investor take its liquidation preference and then share in the remaining proceeds alongside common holders. In a modest exit it can move meaningful value away from founders and employees.
A rising price does not guarantee friendly terms. A headline valuation and a participation right can sit in the same term sheet, and the second can erase some of the benefit of the first. When you compare offers, model the exit waterfall at several outcomes, say a sale at half the post-money, at the post-money, and at two times, before choosing the higher number.
Timelines are shorter
Time between rounds is compressing too. The summary puts median seed-to-Series A time at 664 days, down from a peak of 869. It also reports that the median Series C came 710 days after Series B, 42% faster than a year earlier. Faster cadence helps the companies that are on track and puts more pressure on those that are not, because a gap that once looked normal can now look like a miss.
For planning, that means building the next-round milestones into the current round's use of proceeds. If the market median for seed to A is now under two years, your investors will compare your calendar to it, whether or not they say so.
What to watch
Three things are worth tracking before your next raise.
- Deal count, not just dollars. Dollar totals can rise while the number of companies funded falls. The count tells you how many real chances there are to close.
- Pre-money or post-money. Check which one every benchmark uses before you anchor on it.
- Terms beyond price. Participation, preference stacks and bridge structures are where a headline valuation gets quietly changed.
Carta's next quarterly report should show whether the 21% drop in deal count was a one-quarter dip or the new pattern. Until then, the practical reading is this: capital is available for companies that look like the ones already getting funded, and founders should price their own round against comparable companies at their stage, not against a median that only includes survivors.
This article is information and commentary and is not investment or legal advice. Talk to counsel before signing a term sheet.